" class="no-js "lang="en-US"> AAN Archives - Medtech Alert
Thursday, April 11, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Avidity Biosciences Announces Positive Topline Data from Myotonic Dystrophy Trial

Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called […]

Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting

Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]

Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting

Jazz Pharmaceuticals today announced that eleven abstracts from across its neuroscience portfolio and pipeline, including […]

New Roche Data at 2021 AAN Highlight Neuroscience Portfolio

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data for its approved and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more